Plasma Levels of Soluble HLA-E and HLA-F at Diagnosis May Predict Overall Survival of Neuroblastoma Patients

Table 1

Characteristics and clinical features of NB patients.

Diagnosis
Gender
M	49/84
F	35/84
Age
<18 months	42/84
>18 months	42/84
MYCN
Normal	57/84
Amplified	27/84
Stage
1	7/84
2	8/84
3	22/84
4	42/84
4s	5/84
Followup
Overall survival
CR	41/84
Alive with disease	8/84
Dead	35/84
Relapse-free survival
Relapsed	40/84
Local	7/84
Disseminated	27/84
Both	6/84